Jun 19, 2024 / 12:00PM GMT
Operator
Ladies and gentlemen, good day and welcome the Suven Pharmaceuticals Limited conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Ms. Cyndrella Carvalho, Head of Investor Relations at Suven Pharmaceuticals Limited. Thank you and over to you, ma'am.
Cyndrella Carvalho - Suven Pharmaceuticals Ltd - Head, Investor Relations
Thank you, Darwin. Good evening, everyone. I welcome you all to today's conference call to update on the acquisition of a strategic controlling stake in Sapala Organics. Our management team present here with us today includes Mr. Annaswamy Vaidheesh, Executive Chairman; Dr. V. Prasada Raju, Managing Director; and Mr. Himanshu Agarwal, Chief Financial Officer. Let's dwell into the key highlights of the transaction and (technical difficulty) the floor for Q&A.
Now I invite Mr. Annaswamy Vaidheesh, our Executive Chairman, to share his thoughts on this acquisition.
Vaidheesh Annaswamy - Suven Pharmaceuticals Ltd - Executive
Suven Pharmaceuticals Ltd Acquisition Of Sapala Organics M&A Call Transcript
Jun 19, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers